Inactivation of the phosphoinositide phosphatases Sac1p and Inp54p leads to accumulation of phosphatidylinositol 4,5-bisphosphate on vacuole membranes and vacuolar fusion defects by Wiradjaja, Fenny et al.
Inactivation of the Phosphoinositide Phosphatases Sac1p
and Inp54p Leads to Accumulation of Phosphatidylinositol
4,5-Bisphosphate on Vacuole Membranes and Vacuolar
Fusion Defects*□S
Received for publication, February 2, 2007, and in revised formMarch 28, 2007 Published, JBC Papers in Press,March 28, 2007, DOI 10.1074/jbc.M701038200
FennyWiradjaja‡, Lisa M. Ooms‡, Sabina Tahirovic§1, Ellie Kuhne‡, Rodney J. Devenish‡, Alan L. Munn¶,
Robert C. Piper, Peter Mayinger**, and Christina A. Mitchell‡2
From the ‡Department of Biochemistry andMolecular Biology, Monash University, Clayton 3800, Victoria, Australia, §ZMBH,
University of Heidelberg, INF 282, 69120 Heidelberg, Germany , the ¶Institute for Molecular Bioscience, Queensland Bioscience
Precinct, University of Queensland, St. Lucia, Queensland 4072, Australia, the Department of Physiology and Biophysics,
University of Iowa, Iowa City, Iowa 52242, and the **Division of Nephrology and Hypertension, Oregon Health and
Science University, Portland, Oregon 97239
Phosphoinositides direct membrane trafficking, facilitating
the recruitment of effectors to specific membranes. In yeast
phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) is pro-
posed to regulate vacuolar fusion; however, in intact cells this
phosphoinositide can only be detected at the plasma mem-
brane. In Saccharomyces cerevisiae the 5-phosphatase, Inp54p,
dephosphorylates PtdIns(4,5)P2 formingPtdIns(4)P, a substrate
for the phosphatase Sac1p, which hydrolyzes (PtdIns(4)P). We
investigated the role these phosphatases in regulating
PtdIns(4,5)P2 subcellular distribution. PtdIns(4,5)P2 bioprobes
exhibited loss of plasma membrane localization and instead
labeled a subset of fragmented vacuoles in sac1 inp54 and
sac1ts inp54 mutants. Furthermore, sac1ts inp54 mutants
exhibited vacuolar fusion defects, whichwere rescued by latrun-
culin A treatment, or by inactivation of Mss4p, a PtdIns(4)P
5-kinase that synthesizes plasma membrane PtdIns(4,5)P2.
Under these conditions PtdIns(4,5)P2 was not detected on vac-
uole membranes, and vacuole morphology was normal, indicat-
ing vacuolar PtdIns(4,5)P2 derives fromMss4p-generated plasma
membrane PtdIns(4,5)P2. sac1 inp54 mutants exhibited
delayed carboxypeptidase Y sorting, cargo-selective secretion
defects, and defects in vacuole function. These studies reveal
PtdIns(4,5)P2 hydrolysis by lipid phosphatases governs its spa-
tial distribution, and loss of phosphatase activity may result in
PtdIns(4,5)P2 accumulation on vacuole membranes leading to
vacuolar fragmentation/fusion defects.
Phosphoinositide signaling molecules are phosphorylated
derivatives of phosphatidylinositol (PtdIns)3 that play critical
roles regulating the actin cytoskeleton, cellular proliferation,
and vesicular trafficking (1). PtdIns can be reversibly modified
by lipid kinase phosphorylation of the D-3, D-4, or D-5 posi-
tions of the inositol head group to create phosphorylated phos-
phoinositides that recruit and activate effectors containing
phosphoinositide-binding domains (1). In yeast and mamma-
lian cells, phosphatidylinositol 4-phosphate (PtdIns(4)P) regu-
lates secretion from the Golgi, and PtdIns(4)P recruitment of
specific effector proteins, including FAPP1 and FAPP2, is
required formammalianGolgi to plasmamembrane trafficking
(1–3). In Saccharomyces cerevisiae PtdIns(4)P is synthesized
from PtdIns by three PtdIns 4-kinases, Pik1p at the Golgi, Stt4p
at the plasmamembrane, and Lsb6p at the plasma and vacuolar
membrane (4–7). In yeast, phosphatidylinositol 4,5-bisphos-
phate (PtdIns(4,5)P2) is generated from PtdIns(4)P by the
PtdIns(4)P 5-kinase, Mss4p (8). PtdIns(4,5)P2 is involved in
the regulation of endocytosis, actin cytoskeletal dynamics,
and the maintenance of Golgi structural integrity (1).
Phosphorylated phosphoinositides are dephosphorylated by
lipid phosphatases that regulate the temporal and spatial distri-
bution of phosphoinositide signals. In yeast, PtdIns(4)P and
PtdIns(4,5)P2 are hydrolyzed by phosphoinositide phosphata-
ses, including Sac1p and the inositol polyphosphate 5-phospha-
tases (5-phosphatases), Inp51-4p (9–12). Sac1p is a polyphos-
phoinositide phosphatase containing a CX5R catalytic motif,
which is found in both SacI domain-containing lipid phospha-
tases, as well as dual specificity tyrosine and serine/threonine
phosphatases. Four active SacI domain-containing lipid phos-
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phatases exist in S. cerevisiae, including Sac1p, Fig4p, and two
of the four 5-phosphatases, Inp52p and Inp53p (also called
Sjl2p and Sjl3p) (10, 13). The SacI domain of Inp51p/Sjl1p lacks
the CX5R motif and is therefore catalytically inactive. Sac1p
hydrolyzes PtdIns(4)P, PtdIns(3)P, and PtdIns(3,5)P2 to PtdIns,
but PtdIns(4)P is the preferred substrate (10). Sac1p localizes to
the endoplasmic reticulum (ER) by interaction with dolichol-
phosphate mannose synthase Dpm1p during the exponential
phase of cell growth and translocates to the Golgi when nutri-
ents become depleted (14). Sac1p regulates Golgi membrane
trafficking by controlling PtdIns(4)P levels (15). The sac1 null
phenotype is complex, including altered phosphoinositide
metabolism, accelerated phosphatidylcholine biosynthesis,
cold sensitivity, inositol auxotrophy, hypersensitivity to multi-
ple drugs, actin and cell wall defects, and delayed endocytic and
vacuolar trafficking (16–21). Mutations in SAC1 bypass the
requirement for the phosphatidylinositol transfer protein,
Sec14p, in regulating protein transport from the Golgi to the
plasma membrane (22).
The 5-phosphatases Inp51-4p hydrolyze PtdIns(4,5)P2 form-
ing PtdIns(4)P via their central 5-phosphatase domain. Single
null mutation of any SacI domain-containing 5-phosphatase
shows little phenotype; however, inp51 inp52 and inp52 inp53
double mutants show overlapping functions/phenotype,
including actin cytoskeletal disruption, endocytic defects,
abnormal cell wall integrity, and vacuolar fragmentation (23,
24). Deletion of all three SacI domain-containing 5-phospha-
tases is lethal; interestingly, growth and other defects in the
triple mutant can be rescued by the overexpression of mamma-
lian 5-phosphatase II (25). The yeast 5-phosphatase Inp54p
contains a catalytic 5-phosphatase domain (26) but no SacI
domain. Inp54p localizes to the ER membrane, and deletion of
INP54 results in increased secretion of a mammalian reporter
protein bovine pancreatic trypsin inhibitor by2-fold relative
to wild-type strains (9).
Several lines of evidence suggest that PtdIns(4,5)P2 may play
a significant role in vacuolar function. It has been proposed
that PtdIns(4,5)P2 is important for vacuolar fusion, and
PtdIns(4,5)P2 is itself synthesized during vacuolar fusion and
regulates vacuole ATP-dependent priming and docking (27,
28). Although PtdIns(4,5)P2 has not yet been identified on vac-
uolar membranes in intact yeast cells, in vitro studies revealed
the recruitment of a PtdIns(4,5)P2 biosensor to the vertices (i.e.
the periphery of tightly apposed membranes between docked
vacuoles) of vacuoles in docking reactions (28). In mammalian
cells several PtdIns(4,5)P2 lipid phosphatases, including the
5-phosphatase oculocerebrorenal protein of Lowe (OCRL) and
the recently identified PtdIns(4,5)P2 4-phosphatases, localize to
lysosomal membranes, the mammalian homologue of the vac-
uole (29, 30). OCRL is mutated in patients with Lowe syn-
drome, which includes renal Fanconi syndrome, growth failure,
mental retardation, cataracts, and glaucoma (29). Lysosomal
hydrolase activity is elevated in plasma from Lowe syndrome
patients, relative to age-matched controls (31). These studies
suggest PtdIns(4,5)P2 levels may be tightly regulated on lysoso-
mal/vacuolar membranes.
Previous studies have shown a functional overlap between
some phosphoinositide phosphatases in yeast, although not all
possible phosphatase interactions have been explored (32, 33).
In this study we have examined the phenotype of mutants lack-
ing both SAC1 and INP54. Inp54p hydrolyzes PtdIns(4,5)P2 to
PtdIns(4)P, whereas Sac1p hydrolyzes PtdIns(4)P to PtdIns.We
investigated whether these enzymes coordinately regulate
PtdIns(4,5)P2 metabolism.We demonstrate here that although
the total cellular PtdIns(4,5)P2 levels remain unchanged in sac1
inp54 double mutants, the spatial distribution of PtdIns(4,5)P2
is profoundly altered, accumulating on vacuole membranes. In
these double mutants, vacuolar membrane PtdIns(4,5)P2 is
derived from the plasmamembrane, and its accumulation on
a subset of vacuole membranes is associated with defects in
vacuolar fusion. These studies reveal tight regulation of
PtdIns(4,5)P2 levels at the plasma membrane is required to
regulate vacuolar fusion.
EXPERIMENTAL PROCEDURES
Materials—All restriction and DNA-modifying enzymes
were obtained fromFermentas (Burlington,Canada),NewEng-
land Biolabs (Beverly, MA), or Promega (Madison, WI). Oligo-
nucleotideswere obtained fromGeneWorks (Adelaide,Austra-
lia). All other reagents were from Sigma or Invitrogen, unless
otherwise stated. The constructs pEGFP-N1/PH-PLC1 and
pEGFP-C1/PH-OSBP were kind gifts from Prof. Tamas Balla,
NICHD, National Institutes of Health, Bethesda. GFP-PH-
Num1p construct was a gift from Prof. Mark Lemmon, Univer-
sity of Pennsylvania, Philadelphia. Vph1p antibody was from
Prof. Tom Stevens, University of Oregon, Eugene. Antibody to
Clc1p was a kind gift from Prof. Gregory Payne, UCLA.MFY72
(sac1ts) and AAY202 (mss4ts) strains and constructs encoding
MSS4-GFP and GFP-STT4 were donations from Prof. Scott
Emr, University of California, San Diego. Yeast strains used
in this study are listed in Table 1, and plasmids are listed in
Table 2.
Disruption of SAC1 and/or INP54—Deletion of SAC1 or
INP54 from the SEY6210 strain was as described previously (9,
15). Double null sac1 inp54 and fig4 inp54 mutants and sac1ts
inp54mutants were created by replacing INP54 in the sac1,
fig4 (ResGen/Invitrogen) orMFY72 strains, respectively, with
a LEU2 cassette as described previously (9). This resulted in the
deletion of a segment of chr XV from coordinates 206,284–
204,565, which spans the whole open reading frame of INP54
from nucleotides 1 to 1155, 400 bp upstream of the start codon
and 166 bp downstream of the stop codon. The triple mutant
mss4ts sac1 inp54 was generated by replacing SAC1 with a
TRP1 cassette and INP54 with a URA3 cassette in the mss4ts
(AAY202) strain. The TRP1 sequence was amplified from
pRS424 with the primers 5-atgacaggtccaatagtgtacgttcaaaatgc-
ggacggtatcttcttcaagcttgctatgtctgttattaatttcag-3 and 5-ttaatct-
ctttttaaaggatccggcttggaaaatttaggactgtgcggtatttcacaccg-3. The
PCR product was transformed into mss4ts strains resulting in
the deletion of SAC1 from nucleotides 58 to 1830 or chr XI
coordinates 34,601–36,373, creating a mss4ts sac1 strain.
INP54, including 1602 bp upstream of the start codon and 714
bp downstream of the stop codon, was amplified from SEY6210
genomic DNA using the primers 5-ggctcgagttaaaacgtaagggat-
atgct-3 and 5-gcggccgctgtcgatgtactttatgt-3 and ligated into
an XhoI-NotI-digested pBIIKS() to generate pBINP54.
PtdIns(4,5)P2 on the VacuoleMembrane
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URA3, including its promoter, was amplified from pRS426
using the primers 5-gactagtcgcgcgtttcggtgatgac-3 and 5-cat-
gcatttacttataatacag-3 and cloned into PstI-SpeI-digested
pBINP54 to generate pBINP54URA. The URA3 cassette
flanked by the sequence upstream and downstream of INP54
was recovered from pBINP54URA byXhoI-NotI digestion, and
subsequently transformed intomss4ts sac1 strain resulting in
the deletion of INP54, including 400 bp upstream and 166 bp
downstream of the open reading frame, creating amss4tssac1
inp54 strain. Disruption of each gene was confirmed by PCR
with the use of two unique sets of primers.
Yeast Immunofluorescence—For the detection of Vph1p,
Pep12p, and Clc1p, yeast cells were fixed, spheroplasted, and
stained as described previously (9). Anti-Vph1p and anti-
Pep12p (Molecular Probes) were detected with anti-mouse
Alexa-594 (Molecular Probes) and anti-Clc1p with anti-rabbit
Alexa-594 (Molecular Probes). All other observations of GFP-
tagged proteins were performed in live yeast cells. Fixed or live
cells were placed on poly-L-lysine (2mg/ml)-coated glass slides,
and coverslips were mounted with SlowFade (Molecular
Probes).
Confocal Microscopy—Yeast cells were visualized and ana-
lyzed using either an Olympus Fluoview confocal microscope
or a Leica TCS NT confocal microscope, with green fluores-
cence collected in channel 1 (488 nm excitation, 530  30 nm
emission) and red fluorescence in channel 2 (568 nmexcitation,
LPS90 nm). Images presented in the figures show either cells in
a single field or from several different fields.
Vacuole Labeling—Yeast cells were grown to mid-log phase
and metabolically labeled with 20 M FM4-64 (Sigma) for 15
min at 28 °C in YPD (34), chased in fresh YPD without FM4-64
for 30–120 min as indicated, and viewed by confocal micros-
copy. For analysis of endocytosis (Fig. 5), cells were labeledwith
2 M FM4-64 and viewed by confocal microscopy at the indi-
cated time points. For CMAC-Arg labeling, sac1ts inp54 cells
were incubatedwith 10MCMAC-Arg dye (Molecular Probes)
for 4 h at 28 °C, shifted to 38 °C, further incubated for 2 h, and
analyzed by confocal microscopy. To assay vacuolar fragmenta-
tion or fusion, yeast cells were grown in standard YPD medium,
labeledwithFM4-64 for1h, and thenshifted toYPD0.4MNaCl
or H2O, respectively, for 30 min. All incubation steps were per-
formed at 28 °C, except for sac1ts inp54 cells that were incu-
bated at 38 °C. Approximately 400 cells from three separate
experimentswere scored for vacuolar fragmentation, expressed
as a percentage of the total cell population, and themean S.E.
was determined.
Analysis of Vacuole Function—YPD agar, pH 8.0, was pre-
pared as described (35). Exponentially growing yeast cells were
spotted onto agar plates in 10-fold serial dilutions, starting from
a cell density of 107 cells/ml. To visualize acidified compart-
ments, yeast cells were incubated with 0.2 mM quinacrine
(Sigma) in YPD, pH 8.0, for 5 min at room temperature, as
described previously (36).
Inhibition of Endocytosis—To block endocytosis, sac1ts
inp54 cells expressing 2xPH-PLC-GFP were incubated with
33 g/ml latrunculin A (Molecular Probes) at 28 °C for 1 h,
shifted to 38 °C for 1–2 h, and labeled with 20M FM4-64 or 10
M CMAC-Arg (Molecular Probes).
Subcellular Localization of PtdIns(4)P and PtdIns(4,5)P2—
PH-OSBP was amplified from pEGFP-C1/PH-OSBP using the
primers 5-ggatccaaacaatgggctcggctcgagagggc-3 and 5-ggatc-
cctgccagcatcttcacagc-3, and the resulting PCR product was
cloned into the BglII site of pPGK1303. 2xPH-PLC1 was
amplified from pEGFP-N1/PH-PLC1 using two different sets
TABLE 1
Yeast strains used in this study
Strain Genotype Source
SEY6210 MAT ura3-52 leu2-3, 112 his3-200 trp-901 lys2-801 suc2-9 63
inp54 SEY6210, inp54::LEU2 This study
sac1 (ATY202) SEY6210, sac1::TRP1 15
sac1 inp54 SEY6210, sac1::TRP1, inp54::LEU2 This study
sac1ts (MFY72) SEY6210, sac1::TRP1, carrying pRS416sac1ts-23 41
sac1ts inp54 MFY72, inp54::LEU2 This study
mss4ts (AAY202) SEY6210,mss4::HIS3MX, carrying YCplac111-mss4ts-102 33
mss4ts sac1 inp54 AAY202, sac1::TRP1, inp54::URA3 This study
sac1 inp54 BY4741 (MAT his3-1 leu2-0 met15-0 ura3-0), sac1::KanMX, inp54::LEU2 This study
fig4 inp54 BY4741, fig4::KanMX, inp54::LEU2 This study
vps55 BY4741, vps55::KanMX ResGen
vps27 BY4741, vps27::KanMX ResGen
apm3 BY4741, apm3::KanMX ResGen
TABLE 2
List of plasmids used in this study
Plasmid Description Source
GFP-PH-NUM1 2 URA3 vector expressing GFP at the N terminus of PH-NUM1 44
pPS1303 2 URA3 vector expressing GFP under a GAL promoter 64
pPGK1303 pPS1303 with the GAL promoter replaced by a PGK promoter This study
pPGK1303/2xPH-PLC1 2xPH-PLC1-GFP for localization of PtdIns(4,5)P2 This study
pPGK1303/PH-OSBP PH-OSBP-GFP for localization of PtdIns(4)P This study
pPGK1303/SEC14 SEC14-GFP This study
pPGK-Lys2/2xPH-PLC1 LYS2 plasmid for localization of PtdIns(4,5)P2 in sac1ts inp54 andmss4ts sac1 inp54mutants This study
pRS416-GFP/PIK1 CEN URA3 plasmid expressing Pik1p-GFP under native promoter This study
pRS426/GFP-STT4 2 URA3 plasmid expressing GFP-Stt4p under native promoter S. Emr
pRS426/MSS4-GFP 2 URA3 plasmid expressing Mss4p-GFP under native promoter S. Emr
pBINP54URA For generation ofmss4ts sac1 inp54 strains This study
pPGK423/HA-INP54 2 HIS3 plasmid expressing HA-Inp54p under the PGK promoter This study
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of primers. The first set incorporated a BamHI site at the 5 end
(5-ggatccaaacaatggactcgggccgggac-3) and an EcoRI site at the
3 end (5-gaattccttcaggaagttctg-cag-3), and the second set
incorporated an EcoRI site at the 5 end (5-gaattcatggactcggg-
ccgggac-3) and an XhoI site at the 3 end (5-ctcgagacttcagga-
agttctgcag-3). The two resulting PCR products were ligated
together into BglII-XhoI-digested pPGK1303, and the two PH-
PLC1 fragments simultaneously ligated via their EcoRI ends,
generating two PH-PLC domains in tandem (Table 2). For
expression in sac1ts inp54 and mss4ts sac1 inp54 strains,
2xPH-PLC-GFP1 was cloned in pPGK-Lys2 vector (Table 2).
These constructs were subsequently transformed into yeast
cells, and expression of GFP-tagged PH-OSBP, PH-PLC1, or
PH-Num1p was analyzed live from mid-log phase cultures by
confocal microscopy. sac1 inp54 and sac1ts inp54 cells
showing 2xPH-PLC-GFP on the vacuole were scored as a per-
centage of the total cell population, andmean S.E. was deter-
mined. The proportion of vacuoles expressing 2xPH-PLC-GFP
on their membranes relative to the total vacuole number per
cell was determined the same way. Data were collected from
four independent experiments with at least 400 cells counted.
Expression of Sec14p-GFP and Pik1p-GFP—The full 912-bp
SEC14 coding sequence without the stop codon (chr XIII coor-
dinates 424,988–426,055) was amplified by PCR from the
genomic DNA of SEY6210 strain using the primers 5-agatcta-
tggttacacaacaagaaaaggaattttta-3 and 5-agatctctttcatcgaaaag-
gcttccgg-3, incorporating a BglII site at each end. The resulting
product was cloned into the BglII site of pPGK1303 (Table 2).
The full 3198-bp PIK1 sequence without the stop codon and
1000 bp of upstream sequence (chr XIV coordinates 140,877–
144,074) was amplified by PCR using the primers 5-ggatcctgt-
tccatatctcggtgttgtttg-3 and 5-ggatcccgctatatataccctgtgtaataa-
g-3, incorporating a BamHI site at each end. The product was
cloned in the BamHI site of pRS416-GFP (Table 2).
Analysis of CPY and General Secretion—Metabolic labeling
of CPYwas performed by labeling cells with 25Ci of Easy Tag
Trans35S (Amersham Biosciences) per A600 unit at 25 °C for 5
min, followed by chasing in the presence of excess methionine
and cysteine for the indicated time periods as described previ-
ously (37). CPY was immunoprecipitated using a polyclonal
CPY antibody and separated on 8% SDS-PAGE, followed by
fluororadiography. CPY secretion was detected using a colony
immunoblot assay as described by Roberts et al. (36). The gen-
eral secretion assaywas performed as described previously (38).
Following a 5-min Easy Tag Trans35S labeling and a 30-min
chase, NaF and NaN3 were added to the cells to a final concen-
tration of 20 mM each. The cell suspension was centrifuged to
collect the medium fraction. Cold trichloroacetic acid was
added to a final concentration of 10% to the medium fraction
and incubated on ice for 30 min. Following centrifugation, the
protein pellet was washed twice with acetone and sonicated in
the presence of 2 Laemmli buffer and boiled, and 1 A600 unit
was analyzed on 10% SDS-PAGE. General protein secretion
was detected by fluororadiography.
Analysis of Steady-state Levels of ALP—Extraction of ALP
from yeast cells was performed as described previously (39).
ALP was detected using a monoclonal ALP antibody (Molecu-
lar Probes).
Analysis of Total Cellular Phosphoinositides by HPLC—
[14C]Inositol labeling of yeast, extraction and deacylation of
lipids, and HPLC techniques were performed as described pre-
viously (15). Data were collected from three independent
experiments, and the mean S.E. was determined.
RESULTS
Total Cellular Levels of PtdIns(4,5)P2 Are Unaltered insac1
inp54 Mutants—Inp54p and Sac1p may act sequentially to
regulate PtdIns(4,5)P2 and PtdIns(4)P levels, respectively, on
specific subcellular membranes. To investigate this hypothesis
we generated sac1 inp54 double nullmutants (sac1inp54) in
the SEY6210 strain background. The total cellular phosphoi-
nositide levels were determined in null mutant yeast strains by
labeling cells to equilibrium with [14C]inositol. A dramatic
increase in PtdIns(4)P levels was noted in sac1 cells (Table 3)
(10), but all phosphoinositides, including PtdIns(4)P and
PtdIns(4,5)P2, were normal in inp54 mutants (not shown).
PtdIns(4)P levels were increased insac1inp54mutants sim-
ilar to sac1mutants. PtdIns(4)P levels in sac1mutants were
also not significantly altered by Inp54p overexpression.
PtdIns(3)P and PtdIns(3,5)P2 levels were increased in sac1
compared with wild-type cells, but no further significant alter-
ation was detected in sac1 inp54 mutants or when Inp54p
was overexpressed insac1 strains (Table 3). PtdIns(4,5)P2 lev-
els have been reported to decrease 4–5-fold in sac1 cells in
some studies (40, 41), whereas in three other studies (10, 15, 19)
and as shown here no significant alteration in the levels of
PtdIns(4,5)P2 in sac1 cells was observed (Table 3). These
apparent discrepancies may relate to differences in the yeast
strain and/or technical distinctions in the duration and/or
methods of metabolic labeling. Overexpression of Inp54p in
sac1 mutants did not alter PtdIns(4,5)P2 levels, relative to
wild-type, sac1, or sac1 inp54 strains. Therefore, Inp54p
does not regulate PtdIns(4)P or PtdIns(4,5)P2 cellular levels or
interact with Sac1p to control the total cellular levels of these
phosphoinositides.
PtdIns(4,5)P2 Accumulates on Vacuolar Membranes upon
Loss of Sac1p and Inp54p—When isolated vacuoles were
labeled with a PtdIns(4,5)P2 biosensor and stimulated to
TABLE 3
Total cellular phosphoinositide levels
Strains Phosphoinositides (% total 
14CPtdIns S.E.)a
PtdIns(3)P PtdIns(4)P PtdIns(3,5)P2 PtdIns(4,5)P2
Wild-type 2.63 0.32 2.43 0.12 0.43 0.03 1.23 0.07
sac1 5.27 0.35 23.43 0.98 0.73 0.09 1.0 0.11
sac1 inp54 5.53 0.29 25.07 1.87 0.93 0.09 1.2 0.21
sac1 2 INP54 5.93 0.12 24.93 1.18 0.97 0.07 1.13 0.09
a Data were collected from three independent experiments, and the mean S.E. was determined.
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undergo docking in vitro, PtdIns(4,5)P2 was shown to be tar-
geted to docking sites at vacuole vertices (28). However, in
intact yeast andmammalian cells PtdIns(4,5)P2 is detected pre-
dominantly at the plasma membrane (33, 42, 43), which is sur-
prising given in vitro studies suggest PtdIns(4,5)P2may regulate
vacuolar fusion (27, 28). To examine the spatial distribution of
PtdIns(4,5)P2 in intact yeast, we determined the localization of
the PH domains of mammalian PLC1 and the yeast protein
Num1p, which both bind PtdIns(4,5)P2 with high affinity and
specificity at the plasmamembrane acting as PtdIns(4,5)P2 bio-
sensors (33, 42, 44). In both wild-type (Fig. 1A) and inp54 null
mutant (not shown) strains, 2xPH-PLC-GFP localized
intensely at the plasma membrane, with little cytosolic distri-
bution. This suggests that the 5-phosphatases Inp51-3p may
compensate for the loss of Inp54p in controlling the subcellular
PtdIns(4,5)P2 distribution. In contrast, 2xPH-PLC-GFP fluo-
rescence was redistributed to the cytoplasm in sac1mutants,
and little plasma membrane localization was detected (not
shown), suggesting a decrease in PtdIns(4,5)P2 levels at this site
as reported (44). Strikingly, in sac1 inp54 mutants the
PtdIns(4,5)P2 biosensor was not detected at the plasma mem-
brane, rather fluorescence was either diffusely cytoplasmic
and/orwas intensely concentrated in “ring-like” structures (Fig.
1A). Approximately 400 cells from four independent experi-
ments were scored for 2x-PH-PLC-GFP distribution revealing
that26 3.0% (S.E.) of the double nullmutant cell population
exhibited PtdIns(4,5)P2 biosensor vesicular accumulation with
some cytosolic fluorescence, whereas the remaining cells
showed only diffuse cytosolic fluorescence (see supplemental
Fig. 1 for wide-field image), consistent with decreased plasma
membrane PtdIns(4,5)P2. The percentage of cells exhibiting
vacuolar accumulation of the biosensor may have been under-
estimated because cytosolic fluorescence may obscure faint
vesicular accumulation of the bio-
sensor as the fluorescence signal to
noise ratio is low in cells expressing
the biosensor at low to moderate
levels. Vesicular fluorescence was
not observed in the wild-type or any
single null mutant. The distribution
of the PtdIns(4,5)P2-specific biosen-
sor GFP-PH-Num1p in all strains,
including wild-type, inp54, sac1,
and sac1 inp54 (Fig. 1B, wild-
type and singlemutants not shown),
was the same as that shown with
2xPH-PLC-GFP (Fig. 1A). Specifi-
cally the PtdIns(4,5)P2 biosensor co-
localized with FM4-64 staining of
intracellular membranes in sac1
inp54 mutants. These results sug-
gest PtdIns(4,5)P2 decreases at the
plasma membrane in sac1 inp54
mutants, associated with accumula-
tion of PtdIns(4,5)P2 on intracellu-
lar membranes.
We characterized PtdIns(4,5)P2-
positive vesicles by co-localization
with membrane markers. In sac1 inp54 mutants vesicular
2xPH-PLC-GFP fluorescence co-localized with FM4-64 stain-
ing of vacuolarmembranes (Fig. 1A). In addition, FM4-64 stain-
ing revealed a fragmented vacuolarmorphology in these double
mutants, comprising a single large vacuole surrounded bymul-
tiple smaller vacuoles (see below). However, not all fragmented
vacuoles exhibited PtdIns(4,5)P2 biosensor fluorescence, and
an average of 1.2  0.1 vacuoles per 4.9  0.6 total vacuoles
within an individual cell (of 400 cells scored) exhibited 2xPH-
PLC-GFP fluorescence. Deletion of SAC1 and INP54 in another
yeast strain (BY4741) resulted in vacuolar fragmentation simi-
lar to that observed in the SEY6210 strain, and was associated
with 2xPH-PLC-GFP localization to vacuole membranes (not
shown).
To ensure that PtdIns(4,5)P2 accumulation on the vacuole
was not a secondary phenotype arising from twodeletionmuta-
tions, we employed the use of a sac1ts mutant, in which INP54
was deleted. Yeast cells were grown at the permissive tempera-
ture to early log phase and then shifted to 38 °C for 1–2 h. At the
permissive temperature, the PtdIns(4,5)P2 biosensor localized
to the plasma membrane in sac1ts inp54 cells (Fig. 2A, see
supplemental Fig. 1 for wild-field image); however, after a 1-h
incubation at 38 °C, the intensity of the PtdIns(4,5)P2 biosensor
at the plasma membrane decreased significantly and instead
was concentrated on intracellular vesicles that overlapped with
FM4-64 labeling of endocytic intermediates (arrows) and the
vacuole (arrowheads), respectively (Fig. 2A). By 2 h the
PtdIns(4,5)P2 biosensor exhibited no localization to endocytic
intermediates and only co-localized with fragmented vacu-
oles (Fig. 2A, see supplemental Fig. 1 for wide-field image).
Vacuolar fragmentation was noted only at the nonpermis-
sive temperature.
FIGURE 1. PtdIns(4,5)P2 accumulates on intracellular membranes upon loss of Sac1p and Inp54p. Yeast
were transformed with plasmids encoding either 2xPH-PLC-GFP (A) or GFP-PH-Num1p (B). Live samples were
stained with FM4-64 for 15min and chased for 1 h at 28 °C, except forsac1inp54 cells that were chased for
2 h and analyzed by confocal microscopy. Bar	 5 m.
PtdIns(4,5)P2 on the VacuoleMembrane
JUNE 1, 2007•VOLUME 282•NUMBER 22 JOURNAL OF BIOLOGICAL CHEMISTRY 16299
 at UQ Library on October 9, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
We also examined whether sac1 inp54 inactivation regu-
lated the spatial distribution of PtdIns(4)P, the product of
5-phosphatase hydrolysis of PtdIns(4,5)P2. The localization of
PtdIns(4)P was determined using the PH domain of oxysterol-
binding protein (PH-OSBP) a bioprobe for PtdIns(4)P (42). In
wild-type and inp54 cells, PH-OSBP-GFP localized to punc-
tate Golgi structures (supplemental Fig. 2). Despite the high
levels of PtdIns(4)P in the sac1 and sac1inp54 mutants,
PH-OSBP Golgi fluorescence was unchanged (supplemental
Fig. 2). In additional control studies, we utilized the FYVE
domain of early endosomal antigen 1 (EEA1) tagged to GFP to
investigate the subcellular distribution of PtdIns(3)P, a phos-
phoinositide implicated in vacuolar trafficking (45). FYVE-
EEA1-GFP localized to punctate endosomal structures in
wild-type and all mutant strains (not shown). Therefore, in
sac1inp54 mutants only the spatial distribution of
PtdIns(4,5)P2 is significantly altered.
To confirm vacuolar PtdIns(4,5)P2 localization, 2xPH-PLC-
GFP-decorated vesicles in sac1 inp54 and sac1ts inp54
mutants were co-localized with Vph1p, the 100-kDa subunit of
the vacuolar ATPase (V-ATPase), a vacuolar membrane
marker (Fig. 2B). We noted consistently that FM4-64 or
V-ATPase Vph1p-labeled vesicles coincided with 2xPH-PLC-
GFP fluorescence. To eliminate the possibility that 2xPH-PLC-
GFP-labeled vesicles/vacuoles represent abnormal endosomal
compartments, sac1ts inp54 cells, which had been preincu-
bated at 38 °C for 2 h, were stained with antibodies against the
late endosome resident protein Pep12p. Pep12p localized to
small punctate structures in the cytosol of wild-type, sac1ts
inp54 (Fig. 2C), and sac1 inp54 strains (not shown).
Although some Pep12p punctate structures overlapped with
GFP-2xPH-PLC staining, there was no significant co-localiza-
tion with 2xPH-PLC-GFP-labeled compartments in sac1ts
inp54 (Fig. 2C) andsac1inp54 cells (not shown) suggesting
these structures are not late endosomes. These results are con-
sistent with the contention that PtdIns(4,5)P2 accumulates on
vacuoles and not endosomes.
As PtdIns(4,5)P2 degradation is required for uncoating of
clathrin-coated vesicles (46), we investigated whether clathrin-
coated vesicles accumulate/co-localize with PtdIns(4,5)P2-
coated membranes in sac1 inp54 mutants by immuno-
staining yeast with clathrin light chain (Clc1p) antibodies. The
subcellular localization of the clathrin light chain Clc1p was
similar in wild-type and all mutant strains, and no accumula-
tion of clathrin-coated vesicles or co-localization of Clc1p with
2xPH-PLC-GFP on internal membranes in sac1 inp54
mutants was observed (Fig. 2D, single mutants not shown). To
exclude the possibility that the mislocalization of 2xPH-PLC-
GFP in sac1 and sac1 inp54mutants results from proteol-
ysis of the GFP fusion proteins, anti-GFP immunoblot analysis
of total cell lysates derived from wild-type, inp54, sac1, or
sac1 inp54 mutants expressing 2xPH-PLC-GFP was per-
FIGURE2.PtdIns(4,5)P2-positivevesicles co-localizewithvacuolarmarkers.A, sac1
tsinp54 cells expressing2xPH-PLC-GFPweregrownat 28 °Cand then shifted
to38 °Cforeither1or2h.Cellswereco-labeledwithFM4-64tovisualize intermediateendocytic structures (arrows) and thevacuoles (arrowheads).B,sac1inp54
or sac1ts inp54 cells expressing 2xPH-PLC-GFP were stained with an antibody directed against the 100-kDa subunit of the vacuolar ATPase (Vph1p). Co-
localization appears yellow in merged images. C, wild-type and sac1ts inp54 cells expressing 2x-PH-PLC-GFP were stained with antibodies to the late
endosomalmarker Pep12p. sac1tsinp54 cellswerepreincubatedat 38 °C for 2hbefore staining.D,wild-typeandsac1inp54 cells expressing2xPH-PLC-GFP
were stained with a Clc1p antibody, which binds the light chain of clathrin. Bar	 5 m. Images presented are frommultiple fields.
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formed. Comparable expression of intact GFP fusion proteins
was detected in all strains, with little proteolysis detected (not
shown).
The mislocalization of PtdIns(4,5)P2-binding 2xPH-PLC-
GFP to the vacuolar membrane in thesac1inp54 strain may
result from mislocalization of the enzymes that generate
PtdIns(4,5)P2. To exclude this possibility, the intracellular
localization of the PtdIns 4-kinases Stt4p and Pik1p and the
PtdIns(4)P 5-kinase Mss4p was determined in the sac1, inp54
single and double null mutant cells. Pik1p and Stt4p produce
95%of the total cellular PtdIns(4)P pool and are essential lipid
kinases that contribute to the substrate pool used by Mss4p to
produce PtdIns(4,5)P2 (47). Therefore, the intracellular local-
ization of the recently identified type II PtdIns 4-kinase Lsb6p
(7) was not determined. The intracellular localization of Pik1p,
Mss4p (supplemental Fig. 3, single mutants not shown), and
Stt4p (not shown)was the same inwild-type and all nullmutant
strains. The phosphatidylinositol transfer protein Sec14p
transfers phosphoinositides or phosphatidylcholine between
membranes, an essential step in PtdIns(4)P and PtdIns(4,5)P2
synthesis. Sec14p localized to punctate Golgi patches in wild-
type cells, inp54, sac1, and sac1 inp54 mutants (supple-
mental Fig. 3, single mutants not shown).
Fig4p like Sac1p, contains a SacI domain, and in vitro assays
have revealed it functions as a PtdIns(3,5)P2-specific phosphoi-
nositide phosphatase (13). Fig4p localizes to the limiting mem-
brane of the vacuole and plays a role in regulating the turnover
of vacuolar PtdIns(3,5)P2. Given Sac1p and Fig4p have overlap-
ping substrate specificity, both hydrolyze PtdIns(3,5)P2, we
examined the localization of 2xPH-PLC-GFP in fig 4 inp54
mutants (BY4741 strain background). This PtdIns(4,5)P2 bio-
sensor localized exclusively to the plasma membrane in the
double mutant strain (supplemental Fig. 4). This suggests that
Sac1p regulation of PtdIns(3,5)P2 does not contribute to main-
taining the proper subcellular distribution of PtdIns(4,5)P2.
Loss of Sac1p and Inp54p Leads to Vacuole Fusion Defects—
The cumulative results from the above experiments suggest
Sac1p and Inp54p phosphatases regulate the flux of plasma
membranePtdIns(4,5)P2. In the absence of these lipid phospha-
tases plasma membrane PtdIns(4,5)P2 decreases and accumu-
lates on a subset of fragmented vacuoles. Several questions arise
from these data. First, we asked whether the fragmented vacu-
oles in sac1 inp54mutants indicate a vacuole fusion defect.
Vacuolar fragmentation is a marker of vacuole fusion defects
(48). PtdIns(4,5)P2 is implicated in regulating vacuolar fusion,
based on in vitro studies (27, 28); however, it has never been
detected on vacuole membranes in intact cells. Given that we
had shown PtdIns(4,5)P2 on a subset of vacuolemembranes, we
further characterized the vacuolar fragmentation phenotype of
sac1 inp54 double mutants. Wild-type, inp54, and sac1
strains showed normal vacuole morphology at 28 °C, whereas
the vacuoles of sac1 inp54 mutants were fragmented (see
Figs. 1A and 5 (120 min)). This phenotype was also evident in
sac1ts inp54 cells when incubated at the nonpermissive tem-
perature of 38 °C (Figs. 2A and 5 (120min)), and correlatedwith
the accumulation of PtdIns(4,5)P2 on some vacuolar mem-
branes (Figs. 2A and 4B). It is possible that PtdIns(4,5)P2
becomes trapped on a subset of vacuole membranes that only
fuse with each other, because of the high PtdIns(4,5)P2 levels,
but fail to fuse with other vacuoles, leading to PtdIns(4,5)P2
accumulation on only a subset of membranes.
To analyze specifically for homotypic and/or heterotypic
vacuole fusion defects in sac1 inp54mutants, osmotic shift
FIGURE 3. Vacuole fusion is defective upon loss of Sac1p and Inp54p.
A, yeast cells were stained with 2 M FM4-64 in standard YPD for 1 h at 28 °C
and left untreated or were incubated in YPD containing 0.4 M NaCl (hyperos-
motic) orH2O (hypo-osmotic) for 30min. sac1
tsinp54 cellswere incubatedat
38 °C at all stages. Bar 	 5 m. B, percentage of yeast cells showing frag-
mented vacuoles was determined for each strain. Approximately 400 cells
from three separate experiments were scored as described under “Experi-
mental Procedures,” and the mean  S.E. was determined., wild type; f,
sac1 inp54; , sac1ts inp54.
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experiments were performed. Wild-type vacuoles fragment
under hyperosmotic conditions and in contrast fuse in a hypo-
osmotic environment (49).Wild-type,sac1inp54, and sac1ts
inp54 cells were grown in YPD and then incubated in either
0.4 MNaCl YPD (hyperosmotic) or water (hypo-osmotic) for 30
min. Vacuoles were scored as either nonfragmented or multi-
lobed/fragmented according to the
guidelines described by LaGrassa
and Ungermann (49). We first
examined vacuole responses to
hyperosmotic treatment. Less than
30% wild-type cells showed frag-
mented vacuoles in untreated con-
ditions. Upon hyperosmotic treat-
ment, wild-type cells underwent
vacuolar fragmentation with more
than 50% of cells showing multiple
small vacuoles (Fig. 3, A and B).

80% of sac1 inp54 and 65%
of sac1ts inp54 cells exhibited
vacuolar fragmentation in normal
YPD (untreated), which increased
slightly upon hyperosmotic shock
(Fig. 3, A and B). We next examined
for vacuolar fusion defects. Follow-
ing hypo-osmotic treatment, the
majority of wild-type cells exhib-
ited nonfragmented vacuoles that
had fused into one single large vac-
uole, so that20% of cells exhibited
fragmented vacuoles. In contrast,
following hypo-osmotic treatment
70% of sac1 inp54 and sac1ts
inp54 vacuoles remained frag-
mented, with no evidence of fusion
(Fig. 3,A andB), indicating a general
vacuolar fusion defect. Therefore,
loss of the lipid phosphatases Sac1p
and Inp54p leads to significant vac-
uolar fusion defects.
PtdIns(4,5)P2 on Vacuole Mem-
branes Originates from the Plas-
ma Membrane—We next asked
whether the accumulation of
PtdIns(4,5)P2 on a subset of vacuole
membranes causes the observed
vacuolar fusion defect. This is an
important question as PtdIns(4,5)P2
is proposed to promote vacuole
fusion; however, we noted vacuole
fusion defects despite evidence of
increased PtdIns(4,5)P2 on vacuole
membranes. Second, we asked
where the vacuolar PtdIns(4,5)P2
comes from, given there is no evi-
dence for a substantial vacuole pool
of PtdIns(4,5)P2 in normal yeast.
In yeast the bulk of PtdIns(4,5)P2
is found at the plasmamembrane (33, 44). To evaluate whether
vacuolar PtdIns(4,5)P2 originated from the plasma membrane,
sac1ts inp54 cells were treated with latrunculin A (1 h), which
inhibits endocytosis before shifting to the restrictive tempera-
ture for 1 h (not shown) or 2 h (Fig. 4A). Under these conditions,
FM4-64 was detected on the plasma membrane in latrunculin
FIGURE4.RetentionofPtdIns(4,5)P2at theplasmamembrane rescuesvacuolar fragmentationdefects in
sac1 inp54mutants.A, sac1tsinp54 cells expressing 2xPH-PLC-GFPwere either left untreated or treatedwith
33g/ml latrunculin A (LatA) for 1 h at 28 °C, labeledwith 20M FM4-64 for 15min, and chased for 2 h at 38 °C.
B, untreated sac1tsinp54 cells were incubatedwith 10M CMAC-Arg for 4 h at 28 °C and then shifted to 38 °C
for 2 h (top panel). Arrows indicate the presence of CMAC-Arg in the lumen of 2x-PH-PLC-GFP-decorated
vacuoles. Latrunculin A-treated cells were incubated for 2 h at 38 °C in the presence of 10M CMAC-Arg (lower
panel).C,mss4tssac1inp54 cells expressing 2xPH-PLC-GFPwere labeledwith FM4-64, chased for 1 h at 28 °C
(top panel), and then shifted to 38 °C for 1 h (bottom panel). Bar	 5 m. Images presented are from multiple
fields.
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A-treated cells indicating endocytosis was efficiently blocked
(Fig. 4A). Significantly, the PtdIns(4,5)P2 biosensor distribution
was restricted to the plasmamembrane, and no vacuolar mem-
brane fluorescencewas detected (Fig. 4A). Interestingly, latruncu-
lin A treatment also rescued the vacuolar fragmentation defect in
sac1tsinp54 cells at 38 °C, as detected by the vacuole lumen stain
CMAC-Arg (Fig. 4B, lower panel), consistent with the contention
that PtdIns(4,5)P2 accumulation on vacuolar membranes directly
or indirectly causes the vacuolar fragmentation.
As latrunculin A also inhibits actin polymerization, which
may indirectly affect vacuolar fusion, we also examined the role
of plasma membrane-derived PtdIns(4,5)P2 generated by
Mss4p. MSS4 encodes the type I phosphatidylinositol 4-phos-
phate 5-kinase and is the only known phosphoinositide kinase
in yeast responsible for the synthesis of plasma membrane
PtdIns(4,5)P2 from PtdIns(4)P (8). Mss4p localizes to the
plasma membrane, but it may also undergo phosphorylation-
dependent shuttling between the plasma membrane and the
nucleus (8, 50). To determine whether the vacuolar membrane
PtdIns(4,5)P2 detected in the sac1 inp54 mutants was gen-
erated byMss4p at the plasmamembrane, and next to substan-
tiate the hypothesis that PtdIns(4,5)P2 accumulation on vacu-
ole membranes causes vacuolar fragmentation, a triple mutant
strain containing a temperature-sensitive allele of MSS4 was
constructed,mss4tssac1inp54. Temperature-sensitivemss4
mutants exhibit a 3-fold decrease in total cellular PtdIns(4,5)P2
levels but no obvious vacuole fragmentation (33, 44). At the
permissive temperature, 2xPH-PLC-GFP localized to a subset
of fragmented vacuoles with faint plasmamembrane staining in
this triple mutant (Fig. 4C, see supplemental Fig. 5 for wide-
field image). However, after 1 h at the nonpermissive tempera-
ture, both plasmamembrane and vacuolar 2xPH-PLC-GFP flu-
orescence were significantly attenuated, and a cytosolic
distribution of the PtdIns(4,5)P2 biosensor was detected (Fig.
4C, see supplemental Fig. 5 for
wide-field image). Significantly,
under these conditions the FM4-64-
labeled vacuoles appeared normal
and not fragmented following inac-
tivation of Mss4p, suggesting
PtdIns(4,5)P2 accumulation on the
vacuole may trigger vacuolar frag-
mentation. This is concordant
with our observation that latrun-
culin A-treated sac1ts inp54 cells
did not accumulate PtdIns(4,5)P2
on the vacuole and displayed non-
fragmented vacuoles. Collectively
these studies suggest Sac1p and
Inp54p control the flux of plasma
membrane PtdIns(4,5)P2 and in
their absence PtdIns(4,5)P2 may
accumulate on some vacuolar
membranes leading to vacuolar
fragmentation.
Delayed Endocytic Trafficking to
the Vacuole in sac1 inp54 Double
Mutants—As we have shown evi-
dence of significant redistribution of PtdIns(4,5)P2 in sac1
inp54 double mutants, we examined the functional conse-
quences. Because PtdIns(4,5)P2 plays a role in endocytosis (1),
we investigated whether endocytosis was delayed in sac1
inp54 mutants by examining the internalization of FM4-64.
At 0 min FM4-64 accumulated on the cell surface in wild-type
cells and both single null mutants; by 30 min the dye was pack-
aged into endocytic vesicles, and by 60min FM4-64 reached the
vacuole (Fig. 5, single mutants not shown). sac1 inp54 and
sac1ts inp54 mutants displayed FM4-64 in endosomal com-
partments at 30 min at 28 and 38 °C, respectively, indicating
normal internalization. However, by 60 min FM4-64 remained
localized on punctate endocytic structures, although in a few
cells vacuolar staining was detected. By 120 min FM4-64 had
reached the partially fragmented vacuoles insac1inp54 and
sac1tsinp54mutants (Fig. 5). Therefore, these doublemutants
exhibited evidence of delayed endocytic trafficking to the vac-
uole but normal internalization of endocytic vesicles from the
plasma membrane. These studies suggest a role for Sac1p and
Inp54p in the maintenance of vacuolar homeostasis.
sac1 and inp54 Mutants Exhibit Defects in Biosynthetic Vac-
uolar Trafficking—The fragmented phenotype we observed in
sac1 inp54 double mutants was not unlike that exhibited by
some vps mutants (51, 52). We therefore examined whether
Sac1p and Inp54p function in directing vesicle-mediated traf-
ficking in the endosomal system. Defects in the endocytic path-
way intersect with the Golgi-to-vacuole trafficking pathway at
the level of the late endosome. ER-Golgi-to-vacuole trafficking
was analyzed specifically for the ability to sort and mature the
vacuolar hydrolases. The transport of CPY to the vacuole was
determined by metabolic labeling of cells with trans-[35S]Cys,
Met label, and chasing with excess nonradiolabeled methio-
nine and cysteine. In wild-type and inp54 strains, CPY com-
menced conversion to the mature form within 5 min of chase,
FIGURE 5. Inactivation of Sac1p and Inp54p delays endocytosis. Wild-type and sac1 inp54 cells were
incubatedwith 2Mof the endocytic/vacuolar dye FM4-64 at 28 °C, and cells were viewed live at the indicated
time points by confocal microscopy. sac1ts inp54 cells were preincubated for 1 h at 38 °C before incubation
with FM4-64 at 38 °C. Bar	 5 m. Images presented are from single or multiple fields.
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and by 10 min the prominent species was the mature CPY (Fig.
6A). However, sac1mutants displayed predominantly the ER
p1 form at 10 min, with little mature CPY. After 30 min of
chase, mature CPY (61 kDa) was the dominant form, although
the p1 form still persisted (Fig. 6A), as reported previously (53).
This defective transport and processing of CPY appears to be a
direct consequence of delayed ER to Golgi rather than Golgi-
to-vacuole trafficking, as there was no significant accumulation
of the Golgi p2 form (Fig. 6A) (53). sac1 inp54 double
mutants exhibited the p1 form as the dominant species at all
times, with some p2 andmature forms appearing at 30min (Fig.
6A), suggesting delayed transport from the ER to a greater
extent than that observed in sac1mutants. This delay did not
impact significantly on the total intracellularCPYpopulation as
steady-state sac1 inp54 mutants displayed only the mature
CPY form (not shown).
CPYmissorting is one of the hallmarks of vpsmutants, char-
acterized by misrouting of the Golgi p2 form to the secretory
pathway, resulting in secretion of the precursor CPY into the
extracellular medium (52). sac1 and sac1 inp54 mutants
secreted CPY into the extracellular medium but to a lesser
degree than the class E vps27 mutant or the class A vps55
mutant (Fig. 6B). This weak CPY secretion of sac1 has been
reported previously in a large screen of the yeast genome for vps
genes (51). The VPS-independent pathway of vacuolar traffick-
ing, which bypasses the late endosome, was also assessed via
analysis of ALP at steady-state conditions. Wild-type, inp54,
sac1, andsac1inp54 strains displayed the mature form of
ALP and no precursor ALP, suggesting that transport to the
vacuole via the ALP/AP3 pathway is unaffected in steady-
state conditions; however, we cannot exclude the possibility
that there is a delay in ALP processing that is undetected at
steady-state levels (Fig. 6C). A apm3 mutant, which lacks
one subunit of the AP3 adaptor complex, showed the precur-
sor form of ALP. The soluble smaller form of ALP was also
present at comparable levels in all strains.
Interestingly, several coatomer I (COPI) mutants display
strong CPYmaturation defects with the p1 form retained in the
ER (38). These mutants also exhibit a cargo-specific secretion
defect, in which some proteins are secreted normally, whereas
others are blocked in secretion. To determine whether sac1
inp54 cells are compromised in COPI function, we performed
a general secretion assay (38). Yeast cells were labeled with
trans-[35S]Cys,Met and chased for 30 min. Wild-type, inp54,
and sac1 cells showed a similar pattern in the secretion of
various proteins to themedium; however,sac1inp54 exhib-
ited decreased secretion of proteins with molecular masses of
150, 90, 55, and 33 kDa, relative to wild-type strains (Fig. 6D,
arrows), whereas secretion of proteinswithmolecularmasses of
120 and 52 kDa was not apparent (Fig. 6D, asterisks). This
suggests that inactivation of SAC1 and INP54 leads to impaired
COPI function and thereby cargo-selective secretion defects.
Vacuolar function was assessed by analysis of growth in alka-
line medium (Fig. 7A). Mutants defective in vacuolar acidifica-
tion display increased sensitivity toward extremely acidic or
alkaline medium (54). All strains grew equally well in standard
YPD, but only wild-type, inp54, and sac1 cells grew well on
YPD buffered at pH 8.0 (Fig. 7A).sac1inp54mutants exhib-
ited significant growth defects at pH 8.0. In control studies a
vma2 mutant, which lacks one subunit of the V-ATPase and
thus is unable to acidify the vacuole, failed to grow at pH 8.0
(Fig. 7A). To investigate whether the vacuole insac1inp54 is
properly acidified, yeast cells were incubated with quinacrine, a
weak base that accumulates in acidic organelles (36).Wild-type,
inp54, andsac1 cells accumulated quinacrine in the vacuole,
whereas vma2 mutants did not (Fig. 7B). Surprisingly,
sac1inp54mutants also accumulated quinacrine in the vac-
uole indicating an acidic environment (Fig. 7B). To testwhether
the vacuole in sac1inp54 is acidified after a prolonged expo-
sure to an alkaline environment,sac1inp54 cells were grown
in pH 8.0 YPD medium at a cell density that prevented growth
on YPD plates at pH 8.0 (105 cells/ml). After 6 days of incuba-
tion at 30 °C, sac1inp54 cells failed to increase in cell num-
ber, although the majority was still viable and accumulated
quinacrine in the vacuole (not shown). This suggests that the
vacuole in sac1inp54 mutants is acidified sufficiently to
accumulate quinacrine; however, the growth of these mutant
cells at low cell density is compromised in an alkaline environ-
ment, perhaps because of subtle differences in vacuolar pH
compared with wild-type cells. The presence of vacuole acidi-
FIGURE 6. Inp54p contributes to the function of Sac1p in regulating the
classical vacuolar trafficking pathway. A, yeast weremetabolically labeled
with trans-[35S]Cys,Met and chased with excess nonradiolabeledmethionine
and cysteine at 25 °C. At each time point cell extracts were prepared, and CPY
was immunoprecipitated using a CPY antibody and analyzed by SDS-PAGE
and fluororadiography. p1, ER precursor of CPY; p2, Golgi precursor of CPY;m,
vacuolar mature form of CPY. B, yeast cells spotted on YPD agar plates were
overlaidwithanitrocellulose filter and incubatedat 30 °C for 48h, followedby
immunoblotting with a CPY antibody. vps27 and vps55 strains were
included as positive controls.WT, wild type. C, yeast cell extracts were immu-
noblotted using an ALP antibody to analyze ALPmaturation. apm3mutant
cells were included as a control. p, precursor;m,mature form; s, soluble form.
D, yeast cells were labeled with trans-[35S]Cys,Met and chased with excess
methionine and cysteine for 30min.Mediumwas collected fromeach sample
and protein precipitated with 10% trichloroacetic acid. An equivalent of 1
A600 unit for each sample was analyzed by SDS-PAGE and fluororadiography.
Proteins secreted by all strains are indicated by arrows, and proteins not
secreted by sac1 inp54mutants are indicated by asterisks.
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fication and theV-ATPase subunit Vph1p on the vacuolemem-
brane (see Fig. 2B) indicates that the V-ATPase assembles and
functions properly in sac1inp54mutants.
Thus, in summary sac1 inp54 mutants exhibit impaired
vacuole fusion, delayed endocytosis, delayed ER exit of p1 CPY,
cargo-selective secretion defects, and defects in vacuole
function.
DISCUSSION
The results of the study described here have identified
PtdIns(4,5)P2 vacuolar membrane accumulation following
inactivation of two lipid phosphatases, Sac1p and Inp54p. Evi-
dence to support this contention was demonstrated by the vac-
uolemembrane localization of two PtdIns(4,5)P2-specific bind-
ing domains, which co-localized with vacuole membrane
markers. We demonstrated vacuole membrane accumulation
of PtdIns(4,5)P2 in both sac1 inp54 and sac1ts inp54
mutants, indicating this is notmerely a secondary effect of these
null mutations. Prior to this study, PtdIns(4,5)P2 has not been
detected previously on vacuole membranes in intact yeast cells,
although in vitro studies reported the recruitment of
PtdIns(4,5)P2, PtdIns(3)P, ergosterol andDAG to the vertices of
purified vacuoles in docking reactions (28). Inmammalian cells
although PtdIns(4,5)P2 has not been detected on the mam-
malian homologue of the vacuole, the lysosome, several lipid
phosphatases that hydrolyze PtdIns(4,5)P2 including the
OCRL 5-phosphatase, and two
novel PtdIns(4,5)P2 4-phosphata-
ses localize to lysosomal mem-
branes, suggesting the levels of this
phosphoinositide are tightly regu-
lated at this site (29, 30).
We propose PtdIns(4,5)P2-vacuole
membrane accumulation results
from the trafficking of PtdIns(4,5)P2-
coated vesicles from the plasma
membrane via the endocytic route.
The results that support this hypoth-
esis include firstly, the PtdIns(4,5)P2
biosensor accumulated initially on
endocytic structures in sac1ts inp54
cells at the nonpermissive tempera-
ture prior to vacuole accumulation.
Secondly, latrunculin A treatment
which blocks endocytosis, resulted in
the restrictionof 2xPH-PLC-GFP flu-
orescence to theplasmamembrane in
sac1tsinp54mutants at the nonper-
missive temperature. Thirdly, the
introduction of a temperature sensi-
tive allele ofMSS4, which synthesizes
all PtdIns(4,5)P2 at the plasma mem-
brane, into the sac1 inp54 strain
resulted in redistribution of 2xPH-
PLC-GFP fluorescence from vacuole
membranes to the cytosol at the non-
permissive temperature. Therefore,
PtdIns(4,5)P2 generated by Mss4p at
the plasma membrane is regulated in part by Sac1p and Inp54p,
and in the absence of these phosphatases PtdIns(4,5)P2may accu-
mulate on a subset of vacuole membranes.
PtdIns(4,5)P2 Turnover Is Necessary for Proper Vacuole
Fusion—PtdIns(4,5)P2 has been proposed to regulate vacuole
fusion, specifically priming and docking of vacuoles (27). How-
ever, the accumulation of PtdIns(4,5)P2 on vacuole membranes
of sac1 inp54 double mutants was associated with vacuole
fusion defects. Osmotic shift experiments revealed enhanced
fragmentation insac1inp54 and sac1tsinp54 strains under
hyperosmotic conditions, plus a failure of the fragmented vacu-
oles to fuse in response to hypo-osmotic shift. Interestingly
PtdIns(4,5)P2 did not appear to accumulate on all vacuoles, this
may relate to the sensitivity of the detection of PtdIns(4,5)P2
biosensor, or alternatively, it is possible that PtdIns(4,5)P2 accu-
mulation on the vacuole of sac1 inp54mutants may result from
the fusion of plasma membrane-derived PtdIns(4,5)P2-
decorated endocytic vesicles with one another, rather than
with other vacuole membranes, generating a subset of
PtdIns(4,5)P2-enriched vacuoles.
An interesting question that arises from these observations is
that if PtdIns(4,5)P2 promotes vacuole fusion, why does the
PtdIns(4,5)P2-enriched vacuole not fuse with other vacuoles in
the cell? It is possible that high levels of PtdIns(4,5)P2 may
change the membrane topology of the vacuole. Membrane
topology depends on the lipid composition of the membrane
FIGURE 7. Inp54p and Sac1p maintain normal vacuolar function. A, yeast were grown in 10-fold serial
dilutions starting from 107 cells/ml on standard YPD agar, pH 6.0, or YPD agar buffered to pH 8.0. A vma2
mutant, which lacks one subunit of the vacuolar ATPase and failed to grow at pH 8.0, was included as a control.
B,mid-log phase yeast cultures were incubatedwith 0.2mM quinacrine inminimalmedium at pH 8.0 for 5min
at room temperature. Accumulation of quinacrine indicates acidic compartments. Bar	 5 m.
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bilayer, and changes in lipid composition affectmembrane cur-
vature (for review see (55)). As remodeling of membrane cur-
vature allows budding and fusion of transport vesicles, it is pos-
sible that vacuolar membrane fusion also requires this process.
The high concentration of PtdIns(4,5)P2 on some vacuole
membranes in sac1 inp54mutants may stabilize themembrane
topology to an extent that prevents further changes in mem-
brane curvature. Alternatively, the high concentration of
PtdIns(4,5)P2 may mask other lipids that recruit other proteins
which generatemembrane curvature (reviewed in (56)), or pro-
teins that facilitate vacuole fusion, e.g. PtdIns(3)P recruitment
of Vam7p (57). As yet, it is not clear what happens to
PtdIns(4,5)P2 after vacuole priming and docking. Does it
remain on the vacuole or is it hydrolyzed or sequestered away
prior to fusion? Studies in mice lacking the 5-phosphatase syn-
aptojanin 1 have revealed increased PtdIns(4,5)P2 levels and
accumulation of clathrin-coated vesicles at nerve terminals
(58), indicating the importance of PtdIns(4,5)P2 hydrolysis in
vesicle uncoating, which facilitates fusion. The amount of
PtdIns(4,5)P2 on the vacuole may be critical for correct vacuo-
lar fusion. Evidence from our studies suggests that the bulk of
cellular PtdIns(4,5)P2 has to be sequestered away from the vac-
uole for fusion to proceed correctly, as shown by the nonfrag-
mented vacuoles of sac1 inp54 mutants when PtdIns(4,5)P2
accumulation on the vacuole is abolished by either latrunculin
A treatment or inactivating Mss4p.
Docking of vacuoles, which precedes fusion, also requires
vacuole acidification; this is mediated by the V-ATPase proton
pump that is needed for trans-SNARE complex formation dur-
ing docking (59). Even though the growth of sac1 inp54
mutants was compromised in alkaline medium, their vacuoles
were sufficiently acidic to accumulate quinacrine. Further-
more, the presence of the V-ATPase subunit Vph1p on the
vacuole membrane suggests that the V-ATPase proton pump
assembles and functions properly in these mutants. Therefore,
any defect in vacuole docking/fusion is more likely to be caused
by PtdIns(4,5)P2 accumulation on the vacuole, rather than from
compromised acidification.
We propose that PtdIns(4,5)P2 hydrolysis by lipid phospha-
tases is important for regulating vacuole fusion. Indeed, a
genomic screen of yeast deletion mutants with vacuolar frag-
mentation suggests regulation of PtdIns(4,5)P2 by phospho-
lipaseC is essential for vacuole fusion (48). In the same study, an
inp54mutantwas also found to display vacuolar fragmentation,
in contrast to our findings that inp54 mutants have normal
vacuole morphology. This may be due to strain-specific differ-
ences. Double deletions of INP51, -52, and -53 resulted in frag-
mented vacuoles, again highlighting the importance of
PtdIns(4,5)P2 turnover in regulating vacuole fusion (23, 24).
Possible Functional Interaction of Sac1p and Inp54p in Vac-
uolar Function/Homeostasis—There are four distinct lipid
phosphatases in yeast that hydrolyze PtdIns(4,5)P2 forming
PtdIns(4)P, Inp51-4p. In addition to their 5-phosphatase
domain, Inp52p and Inp53p also contain a SacI-like catalytic
domain, which functions principally to regulate the levels of
PtdIns(4)P, as does Sac1p itself. It has been proposed that
Inp52p and/or Inp53p can each hydrolyze PtdIns(4,5)P2 to
PtdIns(4)P by the 5-phosphatase domain and then PtdIns(4)P
to PtdIns by the SacI-like domain (10). In contrast, Inp51p and
Inp54p do not have a functional SacI-like domain. Although
there is no reason per se to anticipate that Sac1p and Inp54p
should functionally interact and given Inp54p is one of two
yeast 5-phosphatases that does not have a functional SacI
domain, it was possible that Sac1p serves this role for Inp54p.
Equally possible, althoughnot explored here, Inp51pmay inter-
act with Sac1p, as this 5-phosphatase also lacks a functional
SacI domain.
A critical question to address is whether Sac1p and Inp54p
functionally interact to regulate vesicular trafficking and/or
vacuole fusion. The major defects noted in the sac1 inp54
mutants were vacuolar fragmentation and fusion defects,
delayed CPY sorting, a marker of ER-Golgi-to-vacuole traffick-
ing, associated with specific cargo secretion defects, suggesting
impaired coatomer I (COPI) function (38). The latter observa-
tion is consistent with recent studies that revealed members of
theCOPI complex functionally interactwith humanSAC1 (60).
Despite vacuole fusion defects, CPY and FM4-64, although
delayed, and ALP can reach the vacuole in sac1 inp54
mutants. This could be explained by the different requirements
for homotypic vacuole fusion and heterotypic fusion between
other organelles and the vacuoles. A defect in homotypic vacu-
ole fusion does not necessarily indicate a defect in cargo sorting
to the vacuole. For example, the vacuolar v-SNARE Nyv1p is
required for vacuole docking (61), which precedes vacuole-vac-
uole fusion, but it is not required in the biosynthetic pathways
to the vacuole (62). A genomic screen of 4828 nonessential gene
deletions in yeast revealed many mutants with vacuolar frag-
mentation but no vps phenotype (48), which indicates that
there is an overlap as well as distinction between pathways of
trafficking to the vacuole and vacuole-vacuole fusion.
In summary, this study has demonstrated the lipid phos-
phatases Sac1p and Inp54p regulate plasma membrane
PtdIns(4,5)P2 distribution. Although PtdIns(4,5)P2 has been
implicated in vacuolar function, this study shows that
PtdIns(4,5)P2 can accumulate on vacuole membranes in the
absence of specific lipid phosphatases in intact yeast cells and is
associated with vacuole fusion defects.
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SUPPLEMENTARY FIGURE LEGENDS 
 
Supplementary Figure 1. PtdIns(4,5)P2 accumulates on intracellular membranes upon loss of Sac1p and 
Inp54p. Yeast cells were transformed with 2xPH-PLC-GFP plasmids and viewed live under confocal 
microscopy. ∆sac1 ∆inp54 cells were grown at 28°C (top panel), sac1ts ∆inp54 cells were grown at 28°C 
(middle panel), and then shifted to 38°C for 2 hours (bottom panel). Bar = 5 µm. 
 
Supplementary Figure 2. Subcellular distribution of PtdIns(4)P in ∆sac1 ∆inp54 cells. Yeast cells were 
transformed with a plasmid encoding PH-OSBP-GFP. Early log-phase cultures of yeast were viewed live 
under confocal microscopy. Bar = 5 µm. 
 
Supplementary Figure 3. Subcellular localization of enzymes involved in PtdIns(4,5)P2 synthesis. Wild-
type and ∆sac1 ∆inp54 strains were transformed with GFP-tagged PIK1 or MSS4 under their native 
promoters, or SEC14 fused to GFP under a constitutive PGK promoter, and viewed live by confocal 
microscopy. Bar = 5 µm. Images presented are from single or multiple fields. 
 
Supplementary Figure 4.  Double deletion of FIG4 and INP54 does not affect PtdIns(4,5)P2 subcellular 
distribution. ∆fig4 ∆inp54 cells were transformed with plasmids encoding 2xPH-PLC-GFP. Live samples 
were stained with FM4-64 for 15 mins and chased for 1 hour at 28°C, and analyzed by confocal microscopy. 
Bar = 5 µm. 
 
Supplementary Figure 5. Retention of PtdIns(4,5)P2 at the plasma membrane rescues vacuolar 
fragmentation defects in ∆sac1 ∆inp54 mutants. mss4ts ∆sac1 ∆inp54 cells expressing 2xPH-PLC-GFP were 
grown at 28°C (top panel), and then shifted to 38°C for 1 hour (bottom panel). Bar = 5 µm. 
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